A significant discovery in cancer research is emerging with the use of VHH fragments to re-engage damaged p53. This essential tumor inhibitor protein is frequently disabled in various kinds of cancer, causing https://reallivesocial.com/story7657898/mini-antibodies-reactivate-tumor-suppressor-p53-new-new-pathway-for-tumor-management